Ezetimibe
- Product NDC
- 0615-8300
- 11-digit product format
- 006158300
- Labeler code
- 0615
- Product ID
- 0615-8300_0318598c-29b9-4e48-a29b-c22266595eb7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ezetimibe
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, Inc dba Vangard Labs
- Application
- ANDA209838
- Marketing category
- ANDA
- Marketing start
- 2017-08-25
- Marketing end
- 0000-00-00
- Substance
- EZETIMIBE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Decreased Cholesterol Absorption [PE],Dietary Cholesterol Absorption Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0615-8300 | EZETIMIBE TABLET [NCS HEALTHCARE OF KY, LLC DBA VANGARD LABS] | 3 | Legacy NDC | 20250330_f30c3cb1-fb91-4f69-b181-bfb4238635af.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0615-8300-39 | 00615830039 | 30 TABLET in 1 BLISTER PACK (0615-8300-39) | 30 tablet | 2019-07-03 | 0000-00-00 | No | No | Current |